Choi IK - Search Results

1

Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

Huang JH, Zhang SN, Choi KJ, Choi IK, Kim JH, Lee MG, Lee M, Kim H, Yun CO. Huang JH, et al. Among authors: choi kj, choi ik. Mol Ther. 2010 Feb;18(2):264-74. doi: 10.1038/mt.2009.205. Epub 2009 Sep 8. Mol Ther. 2010. PMID: 19738604 Free PMC article.

2

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO. Lee YS, et al. Among authors: choi kj, choi ik. Clin Cancer Res. 2006 Oct 1;12(19):5859-68. doi: 10.1158/1078-0432.CCR-06-0935. Clin Cancer Res. 2006. PMID: 17020994 Free article.

3

Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.

Zhang SN, Choi IK, Huang JH, Yoo JY, Choi KJ, Yun CO. Zhang SN, et al. Among authors: choi kj, choi ik. Mol Ther. 2011 Aug;19(8):1558-68. doi: 10.1038/mt.2011.29. Epub 2011 Apr 5. Mol Ther. 2011. PMID: 21468000 Free PMC article.

4

Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.

Koo T, Choi IK, Kim M, Lee JS, Oh E, Kim J, Yun CO. Koo T, et al. Among authors: choi ik. Hum Gene Ther. 2012 Jun;23(6):609-22. doi: 10.1089/hum.2011.114. Epub 2012 Feb 21. Hum Gene Ther. 2012. PMID: 22248367 Free PMC article.

5

Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.

Choi IK, Li Y, Oh E, Kim J, Yun CO. Choi IK, et al. PLoS One. 2013 Jul 3;8(7):e67512. doi: 10.1371/journal.pone.0067512. Print 2013. PLoS One. 2013. PMID: 23844018 Free PMC article.

6

Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma.

Koom WS, Park SY, Kim W, Kim M, Kim JS, Kim H, Choi IK, Yun CO, Seong J. Koom WS, et al. Among authors: choi ik. J Radiat Res. 2012;53(2):202-10. doi: 10.1269/jrr.11110. J Radiat Res. 2012. PMID: 22510592 Free article.

7

Potent and long-term antiangiogenic efficacy mediated by FP3-expressing oncolytic adenovirus.

Choi IK, Shin H, Oh E, Yoo JY, Hwang JK, Shin K, Yu DC, Yun CO. Choi IK, et al. Int J Cancer. 2015 Nov 1;137(9):2253-69. doi: 10.1002/ijc.29592. Epub 2015 May 26. Int J Cancer. 2015. PMID: 25944623

8

Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.

Oh E, Choi IK, Hong J, Yun CO. Oh E, et al. Among authors: choi ik. Oncotarget. 2017 Jan 17;8(3):4730-4746. doi: 10.18632/oncotarget.13972. Oncotarget. 2017. PMID: 28002796 Free PMC article.

9

Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer.

Jung KH, Choi IK, Lee HS, Yan HH, Son MK, Ahn HM, Hong J, Yun CO, Hong SS. Jung KH, et al. Among authors: choi ik. Cancer Lett. 2017 Jun 28;396:155-166. doi: 10.1016/j.canlet.2017.03.009. Epub 2017 Mar 15. Cancer Lett. 2017. PMID: 28315430

10

Augmentation of rat skin flap viability by relaxin-expressing adenovirus.

Lee WJ, Yun CO, Yun IS, Kim YO, Choi IK, Yun TJ, Rah DK. Lee WJ, et al. Among authors: choi ik. Wound Repair Regen. 2011 Nov;19(6):709-17. doi: 10.1111/j.1524-475X.2011.00733.x. Epub 2011 Oct 12. Wound Repair Regen. 2011. PMID: 22092841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters